http://www.fpnotebook.com/

Mestinon

Aka: Mestinon

Indications
1. Myasthenia Gravis
Components
1. Neostigmine
2. Pyridostigmine
Mechanism
1. Anticholinesterase medications
Dosing
1. Mestinon 60-120 mg every 3-4 hours
2. Doses exceeding 120 mg q3 hours are not more effective
Adverse effects (Especially at higher dose)
1. Gastrointestinal side effects
2. Muscle Fasciculations
3. Eye tearing
Efficacy
1. Not often effective as monotherapy in Myasthenia Gravis

Mestinon (C0700005)
Concepts	Organic Chemical (T109) , Pharmacologic Substance (T121)
MSH	D011729
English	mestinon, Mestinon
Sources	Derived from the NIH UMLS (Unified Medical Language System)

Family Practice Notebook

Patients should address specific medical concerns with their physicians.

Although access to this page is not restricted, the information found here is intended for use by medical providers.

This page was written by Scott Moses, MD, last revised on 10/21/2007 and last published on 2/5/2012.

This is one of 5663 pages in the Family Practice Notebook